Monitoring of ELISA for anti-BP180 antibodies: Clinical and therapeutic analysis of steroid-treated patients with bullous pemphigoid

Journal of Dermatology

Volumn 31, Issue 5, 2004, Pages 383-391

  Izumi, Tomoko ^a   Ichiki, Yoshiro ^a   Esaki, Chikako ^a   Kitajima, Yasuo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Autoantibody; Autoimmunity; Bullous pemphigoid; Enzyme linked immunosorbent assay

Indexed keywords

AUTOANTIBODY; BP180 ANTIBODY; DAPSONE; PREDNISOLONE; STEROID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; AUTOANTIGEN; BP180 AUTOANTIGEN; GLUCOCORTICOID; MINOCYCLINE;

ACCURACY; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLISTER; CLINICAL ARTICLE; DISEASE ACTIVITY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EROSION; FEMALE; FOLLOW UP; HUMAN; MALE; MONITORING; PEMPHIGOID; RELAPSE; TREATMENT OUTCOME; BLOOD; BULLOUS PEMPHIGOID; CASE REPORT; DRUG ADMINISTRATION; EVALUATION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AUTOANTIBODIES; AUTOANTIGENS; DAPSONE; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; PEMPHIGOID, BULLOUS; PREDNISOLONE;

EID: 3042621837     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00689.x     Document Type: Article

References (20)

1. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA: Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting, J Immunol, 136: 1231-1235, 1986.
2. Giudice GJ, Emery DJ, Diaz LA: Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180, J Invest Dermatol, 99: 243-250, 1992.
3. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI: Characterization of bullous pemphigoid autoantigen BP180: A unique basement membrane protein of stratified squamous epithelia, Cell, 24: 897-903, 1981.
4. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D: Isolation of complementary DNA for bullous pemphigoid antigen by use of patient's autoantibodies, J Clin Invest, 82: 1864-1870, 1988.
5. Liu Z, Diaz LA, Troy JL, et al: Passive transfer mouse model of the organ-specific autoimmune disease, bullous pemhigoid, using antibodies generated against the hemidesmosomal antigen, BP180, J Clin Invest, 92: 2480-2488, 1993.
6. Kitajima Y: Blistering mechanisms in bullous pemphigoid after binding of autoantibodies to antigens, Korean J Invest Dermatol, 7: 78-86, 2000.
7. Bedane C, McMillan JR, Balding SD, et al: Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: Evidence that BP180 spans the lamina lucida, J Invest Dermatol, 108: 901-907, 1997.
8. Matunaga T, Shimizu H, Yee C, et al: The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyleterminus extends to the lamina lucida, J Invest Dermatol, 109: 200-206, 1997.
9. Zillikens D, Giudice GJ: BP180/typeXVII collagen: Its role in acquired and inherited disorders of the dermal epidermal junction, Arch Dermatol Res, 291: 187-194, 1999.
10. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA: Bullous pemphigoid and herpes gestationis autoantibodies BP180 ectodomain, J Immunol, 151: 5742-5750, 1993.
11. Zillikens D, Rose PA, Balding SD, et al: Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies, J Invest Dermatol, 109: 573-579, 1997.
12. Zillikens D, Mascaro JM, Rose PA, et al: A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid, J Invest Dermatol, 109: 679-683, 1997.
13. Schmidt E, Obe K, Brocker EB, Zillikens D: Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid, Arch Dermatol, 136: 174-177, 2000.
14. Bystryn JC: Limitation in enzyme-linked immunosorbent assays for antibodies against desmogleins 1 and 3 in patients with pemphigus, Arch Dermatol, 138: 1252-1253, 2002.
15. Toda M, Kobayashi M, Anzai H, Tei S, Amagai M, Nishikawa T: A case of pemphigus vulgaris: Monitoring of disease activity by ELISA, Jp J Clin Dermatol, 56: 1023-1026, 2002.
16. Jordan RE, Kawana S, Frits KA: Immunopathologic mechanisms in pemphigus and bullous pemphigoid, J Invest Dermatol, 85: 72-78, 1985.
17. Lee JB, Fumimori T, Kurose K, Mori O, Hashimoto T: A case of bullous pemphigoid successfully treated by plasmapheresis, J Dermatol, 30: 326-331, 2003.
18. Kitajima Y: Adhesion molecules in the pathophysiology of bullous disease, Eur J Dermatol, 6: 399-405, 1996.
19. Zhu YI, Stiller MJ: Dapsone and sulfones in dermatology, J Am Acad Dermatol, 45: 420-434, 2001.
20. Loo WJ, Kirtschig G, Wojnarowska F: Minocycline as a therapeutic option in bullous pemphigoid, Clin Exp Dermatol, 26: 376-379, 2001.